Current best practices of containment reduce the risks associated with biotech development.
Richard Fink, SM (NRM)
Advertisement
Articles by Richard Fink, SM (NRM)
Advertisement
Latest Updated Articles
Biosafety for Large-scale Operations Using Recombinant DNA TechnologyPublished: September 1st 2005 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
4
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
5
